|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 15/62 | |
| A61K 38/46 | |||
| A61K 47/48 | |||
| A61P 19/08 | |||
| C12N 9/16 |
| (11) | Number of the document | 1759001 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05739065.0 |
| Date of filing the European patent application | 2005-04-21 | |
| (97) | Date of publication of the European application | 2007-03-07 |
| (45) | Date of publication and mention of the grant of the patent | 2011-04-13 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/CA2005/000615 |
| Date | 2005-04-21 |
| (87) | Number | WO 2005/103263 |
| Date | 2005-11-03 |
| (30) | Number | Date | Country code |
| 563828 P | 2004-04-21 | US | |
| 590347 P | 2004-07-23 | US | |
| 614984 P | 2004-10-04 | US |
| (72) |
CRINE, Philippe, CA
BOILEAU, Guy, CA
LEMIRE, Isabelle, CA
LOISEL, Thomas, P., CA
|
| (73) |
Enobia Pharma Inc.,
2901, rue Rachel Est Suite 23, Montréal, Québec H1W 4A4,
CA
|
| (54) | BONE DELIVERY CONJUGATES AND METHOD OF USING SAME TO TARGET PROTEINS TO BONE |
| BONE DELIVERY CONJUGATES AND METHOD OF USING SAME TO TARGET PROTEINS TO BONE |